Cargando…
Homocysteine Is a Marker of Increased Cardio-Cerebrovascular Disease Risk in Psoriatic Patients, but It Does Not Reflect the Effect of Biological Therapy in the Longitudinal Observation
BACKGROUND: Psoriasis is linked to atherosclerosis. Homocysteine (HCYS) has been identified as a marker of increased risk of cardio-cerebrovascular diseases (CCVD) in population. OBJECTIVE: The aim of the study was to determine whether elevated HCYS serves as a marker of increased CCVD in psoriasis...
Autores principales: | Baloghova, Janette, Feketeova, Eva, Kolarcik, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159171/ https://www.ncbi.nlm.nih.gov/pubmed/35685540 http://dx.doi.org/10.1155/2022/3820094 |
Ejemplares similares
-
Vaccination, Risk Factors and Outcomes of COVID-19 Infection in Patients with Psoriasis—A Single Centre Real-Life Experience from Eastern Slovakia
por: Baloghová, Janette, et al.
Publicado: (2022) -
Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems
por: Kaplan, Peter, et al.
Publicado: (2020) -
The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases
por: Li, Jing, et al.
Publicado: (2023) -
The Impact of Aging on Cardio and Cerebrovascular Diseases
por: Izzo, Carmine, et al.
Publicado: (2018) -
Homocysteine and folate levels as indicators of cerebrovascular accident
por: Osunkalu, VO, et al.
Publicado: (2010)